HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved metabolic control in insulin-dependent diabetes mellitus with insulin and tolazamide.

Abstract
The influence of sulfonylurea drugs in enhancing the effect of endogenous insulin is well documented. Furthermore, combination therapy with sulfonylurea and insulin is effective in the treatment of type II diabetes mellitus. Therefore, to assess the efficacy of this type of combination therapy in type I diabetes, we conducted a double-blind clinical trial with tolazamide and insulin in 15 subjects with type I diabetes. The diagnosis of type I diabetes was confirmed by previous episodes of diabetic ketoacidosis and undetectable C-peptide levels in serum samples from blood drawn from patients two hours after breakfast. During the study protocol, placebo or tolazamide was randomly added to insulin and the combination therapy was continued for three months. In the placebo group, levels of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) did not alter significantly at the end of the study period. However, in the tolazamide group, levels of FPG and HbA1c markedly improved after administration of tolazamide (FPG levels before therapy, 10.8 +/- 0.9 mmol/L [mean +/- SEM]; after therapy, 6.7 +/- 0.4 mmol/L; HbA1c levels before therapy, 10.9% +/- 0.6%; after therapy, 9.6% +/- 0.5%). Therefore, adjuvant therapy with tolazamide and insulin may be beneficial in achieving adequate metabolic control in type I diabetes mellitus.
AuthorsU M Kabadi, M R Birkenholz
JournalArchives of internal medicine (Arch Intern Med) Vol. 148 Issue 8 Pg. 1745-9 (Aug 1988) ISSN: 0003-9926 [Print] United States
PMID3041937 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Blood Glucose
  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin
  • Tolazamide
Topics
  • Adult
  • Aged
  • Blood Glucose (analysis)
  • C-Peptide (blood)
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 1 (blood, drug therapy, urine)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Glycated Hemoglobin (analysis)
  • Glycosuria
  • Humans
  • Insulin (administration & dosage)
  • Middle Aged
  • Random Allocation
  • Tolazamide (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: